Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience

Background: Severe eosinophilic asthma decreases lung function and causes worsen symptoms, often forcing recurrent maintenance corticosteroid use. The aim of our real-life study was to evaluate the effectiveness of an add-on treatment with benralizumab in patients with severe eosinophilic asthma, pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Pharmacol
Autori principali: Scioscia, Giulia, Carpagnano, Giovanna Elisiana, Quarato, Carla Maria Irene, Lacedonia, Donato, Santamaria, Sonia, Soccio, Piera, Depalo, Annarita, Fuso, Paolo, Foschino Barbaro, Maria Pia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Pharmacology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928350/
https://ncbi.nlm.nih.gov/pubmed/33679414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.631660
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi